Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients. | Front Immunol | 2023 | 37946732 | PubTator, text mining | PubMed |
| Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer. | Mil Med Res | 2023 | 37941075 | PubTator, text mining | PubMed |
| MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE. | J Immunother Cancer | 2023 | 37940345 | PubTator, text mining | PubMed |
| Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. | Nature | 2023 | 37938773 | PubTator, text mining | PubMed |
| Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses. | Front Immunol | 2023 | 37928529 | PubTator, text mining | PubMed |
| Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality. | Front Immunol | 2023 | 37920475 | PubTator, text mining | PubMed |
| Hedgehog costimulation during ischemia-reperfusion injury potentiates cytokine and homing responses of CD4+ T cells. | Front Immunol | 2023 | 37915586 | PubTator, text mining | PubMed |
| Quantifying the impact of immunotherapy on RNA dynamics in cancer. | J Immunother Cancer | 2023 | 37914385 | PubTator, text mining | PubMed |
| Research progress of single-cell sequencing in tuberculosis. | Front Immunol | 2023 | 37901241 | PubTator, text mining | PubMed |
| CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response. | J Exp Clin Cancer Res | 2023 | 37898752 | PubTator, text mining | PubMed |
| Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37894439 | PubTator, text mining | PubMed |
| Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis. | J Transl Med | 2023 | 37891580 | PubTator, text mining | PubMed |
| Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity. | Front Virol | 2023 | 37886042 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events. | Arterioscler Thromb Vasc Biol | 2023 | 37881939 | PubTator, text mining | PubMed |
| The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment. | Front Immunol | 2023 | 37881432 | PubTator, text mining | PubMed |
| Epidemiological profile of COVID-19 in patients with prostate cancer undergoing androgen deprivation therapy at a Brazilian Cancer Center. | Einstein (Sao Paulo) | 2023 | 37878968 | PubTator, text mining | PubMed |
| Integrated bulk and scRNA sequence identified anoikis-related diagnostic biomarkers and potential association with immune infiltration in type A aortic dissection. | Aging (Albany NY) | 2023 | 37877967 | PubTator, text mining | PubMed |
| Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. | Signal Transduct Target Ther | 2023 | 37875502 | PubTator, text mining | PubMed |
| ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS. | EMBO Rep | 2023 | 37870297 | PubTator, text mining | PubMed |
| [Identification of Peripheral Blood GZMK + CD8 + T Cells As Biomarkers of Alzheimer's Disease Based on Single-Cell Transcriptome]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2023 | 37866940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=22